NEW YORK (GenomeWeb News) – The prenatal genetic testing company Cellscape said that Ted Snelgrove has become its new CEO, effective last week.

Snelgrove previously was VP of sales and marketing for Genomic Health, where he led the commercial development and launch of the Oncotype Dx test. He most recently was chief commercial officer for Crescendo Bioscience, and he has worked in business development, marketing, and product management at Amgen, ALZA, Immunex, and Eli Lilly.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.